Document is current
Any future updates will be listed below
-
Authors
Poret, Alexandra J. https://orcid.org/0000-0002-0723-987X
Schaefers, Matthew https://orcid.org/0000-0001-7454-4180
Merakou, Christina https://orcid.org/0000-0002-2098-599X
Mansour, Kathryn E.
Ahern, Connor D.
Lagoudas, Georgia K. https://orcid.org/0000-0002-3165-7801
Haynes, Alyssa https://orcid.org/0000-0001-8350-2820
Cross, Ashley R.
Goldberg, Joanna B. https://orcid.org/0000-0002-5285-5188
Kishony, Roy https://orcid.org/0000-0002-5013-5072
Uluer, Ahmet Z.
McAdam, Alexander J.
Blainey, Paul C. https://orcid.org/0000-0002-4889-8783
Vargas, Sara O.
Lieberman, Tami D. https://orcid.org/0000-0001-5430-3937
Priebe, Gregory P. https://orcid.org/0000-0001-9831-0354
- License Information
-
More Information
Article History
Received: 13 January 2025
Accepted: 12 June 2025
First Online: 23 July 2025
Competing interests
: P.C.B. is a consultant to or holds equity in 10× Genomics, General Automation Lab Technologies/Isolation Bio, Celsius Therapeutics, Next Gen Diagnostics, Cache DNA, Concerto Biosciences, Stately, Ramona Optics, Bifrost Biosystems, and Amber Bio. His laboratory has received research funding from Calico Life Sciences, Merck, and Genentech for unrelated work. The remaining authors declare no competing interests.
